04/15/2024
5:27 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
4:02 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:14 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:25 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:54 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/21/2024
7:00 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/07/2024
3:40 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:45 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
5:47 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
6:36 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:39 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:42 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:49 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
4:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
4:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/26/2024
7:43 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:37 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:51 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G/A | |
02/09/2024
7:50 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
7:10 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:24 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G/A | |
02/06/2024
3:55 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
4:44 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
4:47 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
4:48 PM | Atlas Venture Opportunity Fund II, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
4:12 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
4:12 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
8:44 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
8:51 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:24 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:15 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:16 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:28 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:04 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:09 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:11 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
12/15/2023
5:15 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
12/15/2023
5:18 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
The Next Step of Their Control Is Here … (Ad) Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years.
What does this mean?
It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late. |
12/15/2023
3:48 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/14/2023
7:13 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
7:14 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:40 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:44 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:15 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:15 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:53 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:58 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:00 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:03 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:42 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
3:19 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
3:19 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
7:35 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
11:11 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
11:15 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form EFFECT | |
12/05/2023
3:51 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
12/05/2023
3:53 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form POS AM | |
12/05/2023
3:53 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form POS AM | |
12/05/2023
3:21 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
11:15 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form EFFECT | |
11/22/2023
3:18 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Khara Rahul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
5:46 AM | AI DMI LLC (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13D/A | |
11/09/2023
7:35 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:45 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
5:22 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:23 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Khara Rahul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
8:05 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
8:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
3:38 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
10/10/2023
3:40 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:06 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:56 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
09/21/2023
3:44 PM | Atlas Venture Fund X, L.P. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13D/A | |
09/18/2023
3:59 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:44 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:32 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:15 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:16 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
5:55 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:15 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:32 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:17 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
7:10 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/30/2023
5:29 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
MacDonald Brian Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:49 PM | Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G | |
06/30/2023
3:19 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/30/2023
3:12 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:17 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
4:22 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
06/28/2023
4:01 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
4:04 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:22 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
3:53 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
06/16/2023
6:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
8:44 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
